Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023
2023年11月3日 - 5:05AM
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
medical technology company focused on surgical solutions for the
treatment of spinal disorders, today announced that it will release
its financial results for the third quarter ended September 30,
2023, before the open of the financial markets on Thursday,
November 9, 2023.
Sean Browne, President and Chief Executive
Officer, and Scott Neils, Chief Financial Officer, will host a
conference call on Thursday, November 9 at 9:00 AM ET to review
results.
Conference Call
Details:Conference Call Date: Thursday,
November 9, 2023 - 9:00 AM ETConference Call
dial-in: 877-407-6184International
dial-in: 201-389-0877Conference Call
Name: Xtant Medical Q3 2023 Financial
ResultsWebcast Registration: Click Here
Following the live call, a replay will be
available on the Company’s website, www.xtantmedical.com, under
“Investor Info.”
About Xtant Medical Holdings,
Inc.
Xtant Medical Holdings, Inc.
(www.xtantmedical.com) is a global medical technology company
focused on the design, development, and commercialization of a
comprehensive portfolio of orthobiologics and spinal implant
systems to facilitate spinal fusion in complex spine, deformity and
degenerative procedures. Xtant people are dedicated and talented,
operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and
registered trademarks of Xtant Medical Holdings, Inc. or its
affiliates, registered as indicated in the United States, and in
other countries. All other trademarks and trade names referred to
in this release are the property of their respective owners.
Investor Relations Contact
David CareyLazar FINN PartnersPh:
212-867-1762Email: david.carey@finnpartners.com
Xtant Medical (AMEX:XTNT)
過去 株価チャート
から 4 2024 まで 5 2024
Xtant Medical (AMEX:XTNT)
過去 株価チャート
から 5 2023 まで 5 2024